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ABSTRACT
Background
 Hepatic encephalopathy is found in 50-70% cases of liver cirrhosis. Management of hepatic encephalopathy
is based on the hypothesis of ammonia and false neurotransmitters. A vegetable diet is the diet of choice, since
vegetable proteins have a high biological value, contains non-ammonigenic essential amino acids, and contains
fiber. The results of soy fermentation by Rhizopus sp can increase the nutritional value to make it easier for body
digestion.
Study aim
To determine improvements in hepatic encephalopathy by measuring the ammonium level and determining
the psychometric test in patients with liver cirrhosis receiving a tempe diet compared to those receiving a
liver diet (conventional diet).
Method
This is a random open clinical trial with a proportional stratification according to the Child Pugh
criteria. Study subjects are patients with liver cirrhosis who are hospitalized at the Internal Medicine Ward
and ambulatory patients at the out-patient Gastro-hepatology Polyclinic of Dr. Sarjito Public General
Hospital, from January 1999 to May 2000. The trial was conducted for 20 days, where the first (trial) group
was given a tempe diet, while the second (control) group was given liver diet II/III (conventional). Measured
outcomes include peripheral blood ammonium level, and psychometric test using the Numeric Connection
Test (NCT).
Results
In the first group, we found a significant reduction of ammonium level in Child-Pugh A patients and
a non-significant reduction in Child-Pugh B/C patients, a non-significant psychometric test improvement in
Child-Pugh A patients, and significant psychometric test improvement in Child-Pugh B/C patients. In group
II: there is no significant difference in the changes in ammonium level or psychometric test in patients from
both Child-Pugh categories.
Conclusion
A 20-day tempe diet can reduce ammonium levels and improve results on the psychometric test.
Key words: liver cirrhosis, hepatic encephalopathy, tempe diet, numeric connection test, Child-Pugh
criteria
INTRODUCTION
Hepatic encephalopathy is found in 50-70% of patients
with liver cirrhosis.3 Hepatic encephalopathy that occurs
in liver cirrhosis is chronic in nature, and is also known as
porto-systemic encephalopathy. It is a complex neuro-
psychiatric syndrome characterized by depression of the
central nervous system of various  degrees, caused by
hepatic insufficiency. It is a reversible abnormality.4,5
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Chronic hepatic encephalopathy is characterized by
reduced daily activity, reduced intellectual function, or
psychomotor dysfunction, reduced EEG frequency,
increased ammonium level, and abnormal psychomotor
test results.4,6 Most of patients with hepatic
encephalopathy take the form of sub-clinical hepatic
encephalopathy (no clinical mental or neurological
abnormality, but abnormal psychometric test results). The
prevalence varies from 30-84%, depending on the type
of psychometric test and population. There is still no gold
standard for the diagnosis of sub-clinical encephalopathy.
There is an increased prevalence from Child Pugh A
from 14% to 45%.5,7
The pathogenesis of chronic hepatic encephalopathy
is as follows: there is an increase in amino acid transport
through the blood brain barrier, increased cerebral
energy metabolism, influence of neurotoxins produced
by intestinal flora, changes in cerebral
neurotransmitters, and other factors (mangan, H. pylori,
and reduced cholin/creatinine ratio).4
There are two basic principles in the management of
hepatic encephalopathy, which is generally based on the
pathophysiological background, and is associated with
the clinical type of encephalopathy (acute liver failure
encephalopathy, liver cirrhosis with a trigger factor,
chronic encephalopathy, and sub-clinical encephalopathy).8
The study is conducted mainly based on the ammonia or
false neurotransmitter hypothesis. Treatment based on
the ammonia hypothesis comprises of reducing ammonia
production (protein restriction, vegetable diet,
carbohydrate enema, lactulose, oral lactytiol, and oral
antibiotics), and increasing ammonia metabolism
(ornithine aspartate, sodoum benzoate, phenylacetate, zinc
supplementation). Therapy based on the false
neurotransmitter hypothesis takes the form of
administration of branched amino acid, levodopa,
bromocriptine, flumazenyl, disodium calcium edentate,
and sodium para-aminosalicyl acid.3,4,5
Tempe is a source of vegetable protein from the
fermentation of soybean by rhizopus. The protein
content after fermentation is better than prior to
fermentation, since there is an increase in free fatty acid
and the protein content is more easily absorbed. Tempe
has been proven to be beneficial in reducing cholesterol,
improving digestion, as well as anti-virus and
anticancer agents.9,10 Vegetable proteins contain little
non-N- proteins, produces little ammonia, and is easily
tolerated by the body. Proteins that greatly produce
ammonia are glycine, serine, treonine, glutamine,
hystidine, lysine, and aspargine (many of which are found
in milk, eggs, and meat).11,12
There is very few studies on the effect of dietary
regulation in patients with liver cirrhosis for prevention
of hepatic encephalopathy. This study aims to determine
improvements of hepatic encephalopathy by measuring
the ammonium level and conduct psychometric testing
on patients with liver cirrhosis receiving a tempe diet,
compared to those receiving the conventional (liver) diet.
MATERIALS AND METHOD
The study was conducted in the Internal Department
Ward and the Gastroenterology Polyclinic at Dr. Sardjito
Public General Hospital, from January 1999 to May 2000.
Study subjects were patients with liver cirrhosis
diagnosed based on the Subandiri criteria and ultrasound
examination. The study was conducted as an open
clinical trial.
Inclusion criteria include: all patients with liver
cirrhosis who are in stabile condition, living in the
Yogyakarta Special Provincial Area. Exclusion criteria
included: correction for bleeding (hematemesis/melena),
renal failure (hepatorenal syndrome), severe infection,
electrolyte imbalance, liver malignancy, precomatous
conditions and hepatic coma. Patients that fulfilled the
criteria were given an explanation on the aim and
benefit of the study before they gave their consent and
signed the informed consent form.
The degree of severity is based on the Child Pugh
Criteria (A, B, and C) with laboratory evaluation
(albumin, bilirubin, and prothrombine time), ascites, and
the degree of hepatic encephalopathy. Ammonium
evaluation is conducted using the amicheck meter II, and
psychometric testing using the numeric connection test
(NCT).
Study subjects were stratified into 2 groups, those in
Child Pugh category A and those in categories B or C.
Subjects from each category were randomized using a
random table to determine the form of management. The
first (trial) group in each category received a soy tempe
diet (liver diet without meat proteins, with a protein
requirement met from 30-40 grams of tempe per day).
The second (control) group of each category was given
(conventional) liver diet II/III (liver diet with meat and
vegetable proteins). The tempe diet composition was as
follows: rice/rice porridge, vegetables, 100 grams of soy
tempe, fruits, 2 x 12.5 gram tempe milk (approximately
30-40 grams of protein). The second liver diet
composition was as follows: rice porridge, vegetables,
50 grams of meat/25 gram of egg, and fruit
(approximately 30 grams of protein). The third liver diet
composition is as follows: rice/rice porridge, 100 gram
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of meat/egg, 50 gram of tempeh, vegetables, and fruit 
(approximately 50 grams of protein). 
The study was conducted for 20 days. During  
hospitalization, an expert nutritionist arranged the menu.  
When the patient was ready to be released, the tempe  
diet is continued at home in forms of the patient’s  
preference, as long as it was in accordance with the  
liver diet. The patient is monitored every 3 days. To  
determine the dietary intake, there is a list to be filled by  
nutritionists or the patient’s family. Medications for liver  
cirrhosis were continued. 
The outcome measured was the ammonium level and  
psychometric test results (NCT). In addition to changes  
in the ammonium level (ug/dl) and the time required to  
complete the NCT test (in seconds), the ammonium level  
is evaluated using the ammonium level classification by  
Conn et al, 1984,6 and classification of prolonged time  
based on Sanyal et al, 1994.13 The data were managed  
using the computer program SPSS 6.0 for windows.  
Ammonium levels and NCT test results were displayed  
in the form of the mean and standard deviation, and were  
analyzed using the t test and two-tailed test. On the other  
hand, changes in ammonium level and prolonged NCT  
test were analyzed using the non-parametric (x2 test,  
Wilcoxon matched-pair, signed rank test). The sig- 
nificance limit was p<0.05. 
 
RESULTS 
Sixty-three patients with liver cirrhosis consented to  
participate in the study, 23 of which were classified as  
Child Pugh class A, 28 as Child Pugh class B,  and 12  
patients in Child Pugh class C. Based on the random  
table, the first (trial) group I consisted of 12 Child Pugh  
A patients, 13 Child Pugh B patients, and 6 Child Pugh 
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C patients (with a total of 31 patients). The second 
(control) group consisted of 11 Child Pugh A patients,  
15 Child Pugh B patients, and 6 Child Pugh C patients  
(with a total of 32 patients). The mean age of Child Pugh  
B/C patients in group I was 55.18 ± 10.8 years, and in  
group II was 56.17 ± 13.65 years. For Child Pugh A  
patients, the mean age was 54.73 ± 10.20 years for group  
I and 53.45 ± 12.94 years for group II. There were 4  
patients excluded from the study, since 1 patient from  
the first group of Child Pugh A patients suffered from  
bleeding (hematemesis), while 3 patients had a  
worsened condition (1 from Child Pugh C group II, 1  
from Child Pugh B group I, and 1 from Child Pugh C  
group I). 
Table 1 demonstrates the results of ammonium level  
and psychometric test (NCT) for each category and  
group at the beginning (initial point) and at the end (final  
point) of the study. The mean initial ammonium level in  
group I Child Pugh A was 181.36 ± 64.48 ug/dl, while  
the final ammonium level was 135.27 ± 42.10 ug/dl. This  
demonstrates a significant reduction with a p of 0.0030.  
The average ammonium level in group II Child Pugh A  
was 152.0 ± 42.41 ug/dl, while the final ammonium level  
was 170.55 ± 48.41 ug/dl, demonstrating no significant  
change (p=0.378). The average initial psychometric test  
(NCT) in group I Child Pugh A patients was 44.55 ±  
16.79 seconds, while at the end of the study (the final  
results) was 39.00 ± 9.89 seconds, demonstrating no  
significant change (p=0.114). The mean initial  
psychometric test results (NCT) group II Child Pugh A  
was 49.18 ± 18.90 seconds, while the final results was  
45.09 ± 24.25 seconds, demonstrating no significant  
change (p=0.594). 
35  
Table 1. Ammonium Level and Psychometric Test Results (NCT) and Liver Cirrhosis Patients Group I  (trial) and 
Group II (control) 
 Group I Group II 
 Initial Final  Initial Final p         
 () (CI 95%) () (CI 95%) 
CP A   
- Amonia     181,3664,48 135,2742,1 0,030*   11 152,042,4 170,5548,41 0,379  11 
 (-46,0960,56) (5,394;86,788) (25,2764,15) (-63,318;26,227) 
- NCT            44,5616,79 39,09,89 0,114 49,1818,9 45,0924,25 0,594 
 (-6,459,72) (-1,581;12,672) (-2,6424,78) (-12,466;20,648) 
CP B/C   
- Amonia     216,8877,15 183,048,1 0,113    17 277,0565,6 217,2588,22 0,163 20 
 (-34,4183,36) (-1,7891,76) (-13,213;72,813)  
- NCT         105,2968,99 76,9445,75 0,004* 109,3564,54 97,968,18 0,075 
 (-28,3535,17) (10,263;46,442) (-8,2825,97) (-1,261;24,161) 
* p<0,05  
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The mean ammonium Child Pugh B or C group I 
was 216.88 ± 77.65 ug/dl at the beginning of the study  
(the initial level) and 183.0 ± 48.10 ug/dl at the end of  
study (the final level), without any significant change  
(p=0.113). The mean ammonium of Child Pugh B or C  
group II was 247.05 ± 65.60 ug/dl at the beginning of the  
study (the initial level), and 217.25 ± 88.22 seconds at  
the end of the study (the final level), without any  
significant change (p=0.163). The mean psychometric  
test (NCT) of the group I in Child Pugh B and C was  
105.29 ± 68.99 seconds at the beginning of the study  
(the initial level) and 105.29 ± 64.54 seconds at the end  
of the study (the final level), demonstrating a significant  
change (p=0.004). The mean NCT test results of group  
II Child Pugh B or C was 109.35 ± 64.54 seconds at the  
beginning of the study (the initial level) and 97.9 ± 68.18  
at the end (the final level), demonstrating no significant  
change (p=0.075) (Table 1). 
Changes in the ammonium level based on the  
classification of ammonium level in Group I Child Pugh  
class A patients demonstrated a significant change  
(p=0.043, z=-2.0284), where at the beginning of the study 
36% (4) were at the level zero, 18.2% (2) were at level 
1, 27.3% (3) were at level 2, and 18.2% (2) were at 
level 3; while at the end of the study the number changed to 
63.6% (7) for level 0 and 36.4% (4) at level 1, while for 
group 2 Child Pugh cases there was no significant 
change (p=0.314, z =-1.007) (Table 2). In Child Pugh B/ C 
patients, there was no significant change (p>0.05) in the 
two groups. (Table 2) 
There was no significant difference in the change in  
the time needed to finish the psychometric test in  
patients with Child Pugh A patients according to the  
classification (levels) in each group (p>0.05). While in  
the first group of Child Pugh B/C patients there was a  
significant difference (p=0.018; z=-2.3664). At the  
beginning of the study, there were 29.4% (5) in level 0;  
17.6% (3) in level 1; 5.9% (1) in level 2; 11.8% (2) in  
level 3, and 35.3% (6) in level 4, while at the end of the  
study, there were 41% (7) in level 0; 5.9% (1) in level 1;  
11.8% (2) in level 2; 35.3% (6) in level 3; and 5.9% (1)  
in level 4. While in group II, no significant change was  
found (Table 3).  
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Table 2. Changes in Ammonium Level in Group I (trial) and Group II (control) Patients With Liver Cirrhosis
Level 
(ug/dl) 
Child Pugh A Child Pugh B/C 
 Group I (11) Group II (11) Group I (17) Group II (20) 
 Initial 
(%) 
Final 
(%) 
Initial 
(%) 
Final 
(%) 
Initial 
(%) 
Final 
(%) 
Initial 
(%) 
Final (%) 
0(150) 4(36,4) 7(63,6) 6(54,4) 5(45,4)   4(23,5) 3(17,6) - 3(25) 
1(151-200) 2(18,2) 4(36,4) 4(36,4) 3(27,3)   2(11,8) 9(52,9) 5(25) 6(30) 
2(201-250) 3(27,3) - 1(9,1) 3(27,3) 7(41,2) 4(23,5) 5(25) 4(20) 
3(251-300) - - - - 2(11,8) 1(5,9) 6(30) 3(15) 
4(300) - - - - 2(11,8)  4(20) 4(20) 
 z=-2,0284 z=-1,007    z=-1,5115 z=-1,5724 
 p= 0,0043* p= 0,314  p= 0,131     p= 0,116 
* p<0,05 
 
Table 3. Changes in Psychometric Test Results in Group I (trial) and Group II (control) Patients With 
Liver Cirrhosis 
Child Pugh A Child Pugh B/C 
Group I (11)   Group II (11) Group I (17) Group II (20) 
Level 
> time#   
(second) Initial 
(%) 
Final 
(%) 
Initial 
(%) 
Final 
(%) 
Initial 
(%) 
Final 
(%) 
Initial 
(%) 
Final 
(%) 
0(15)           7(63,6) 8(672,7) 6(54,5)    7(63,6)       5(29,4)    7(41,2)     3(15)      5(25) 
1(15-30)        1(9,1) 3 (27,3) 2(18,2)   3(27,3)       3(17,6)     1(5,9)       3(15)      2(10) 
2(31-60)        3(27,3) - 3(27,3)      -              1(5,9)       2(11,8)     4(20)     4(20) 
3(61-120)         -    -   - - 2(11,8)     6(35,3)     5(25)     5(25)     
4(120)            - - - - 6(35,3)       1(5,9)       5(25)     4(20) 
 z=-1,1351 z=-0,5394 z=-2,3664 z=-1,6903 
 p= 0,249 p= 0,590 p= 0,018* p= 0,091 
* p<0,05 
#NCT test time counts with prolonged time in 30 second.  
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DISCUSSION
The prevalence rate of hepatic encephalopathy reported
to the Department of Internal Medicine at Dr. Sardjito Public
General Hospital was 11.7%, with  bleeding as the main
cause.14 In abroad, hepatic encephalopathy has not been
completely evaluated, and study had only been conducted
on factors supporting the hypothesis for hepatic
encephalopathy, which are increased ammonium levels and
abnormal psychometric testing unaccompanied by EEG
evaluation. A similar study with long term AARC
supplement has also been performed.6
According to the study on 20-day tempe diet, there was
a significant reduction of ammonium level in Group I Child
Pugh A patients. Such results were in line with the
ammonium level (z = -2.0284; p = 0.043). Improvements in
psychometric testing do not  demonstrate a significant change,
probably because in the two groups for Child Pugh A, most
of the results of the NCT test at the beginning of the study
was level 0, at 63.6% (group I), and 54.5% (group II).
The mean reduction in ammonium level in the first group of
Child Pugh B/C patients was 34.41 ± 83.36, while in the second
group it is 1.78 ± 91.76. But in the two groups, the reduction did
not show a significant   difference (p>0.005). Improvements in
the psychometric test in group I Child Pugh B/C demonstrated
a significant reduction to 28.35 ± 35.17 seconds, p=0.004, while
in the second group there was no significant improvement. This
was also supported with improvements in test results based on
the level  (z = -2.3664; p = 0.018).
During the study, there were no complaints (diarrhea,
constipation, and vomiting). Only several patients complained
of nausea and vomiting after drinking the tempe milk, due
to an unpleasant aroma. Most patients feel better after
consuming a tempe diet. The limitations of this study is as
follows: inability to control other dietary intake, different
ability of patients to finish their tempe diet, boredom
towards a tempe diet after the   patient returns home, and
limitations in instruments, money, and time for the study.
CONCLUSION
Based on the study results we could conclude that
administration of a tempe diet for 20 days in patients with
liver cirrhosis:
1. Could significantly reduce the ammonium level in Child
Pugh A patients and was not significant in Child Pugh
B or C compared to patients receiving the
(conventional) liver diet.
2. Was able to significantly improve the time needed for
the psychometric test in patients with Child Pugh B or
C compared to Child Pugh patients B or C   receiving
the (conventional) liver diet.
SUGGESTION
There are still need more specific study with double
blind method. For anticipate study bias, the diet tempe with
consider the quality of tempe is needed for that study.
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